In Silico Design and Enantioselective Synthesis of Functionalized Monocyclic 3‐Amino‐1‐carboxymethyl‐β‐lactams as Inhibitors of Penicillin‐Binding Proteins of Resistant Bacteria

Saved in:
Bibliographic Details
Title: In Silico Design and Enantioselective Synthesis of Functionalized Monocyclic 3‐Amino‐1‐carboxymethyl‐β‐lactams as Inhibitors of Penicillin‐Binding Proteins of Resistant Bacteria
Authors: Decuyper, Lena, Deketelaere, Sari, Vanparys, Lore, Jukič, Marko, Sosič, Izidor, Sauvage, Eric, Amoroso, Ana Maria, Verlaine, Olivier, Joris, Bernard, Gobec, Stanislav, D'hooghe, Matthias
Contributors: FWO - Research Foundation Flanders, Slovenian Research Agency, BELSPO - Belgian Federal Science Policy Office
Source: CHEMISTRY-A EUROPEAN JOURNAL
Publisher Information: Wiley, 2018.
Publication Year: 2018
Subject Terms: Enterococcus faecium, Drug Resistance, Bacterial/drug effects, Anti-Bacterial Agents/chemistry, Bacterial Infections/drug therapy, LEAVING GROUP, CEPHALOSPORINS, Functionalized, 01 natural sciences, antibiotics, beta-Lactams/chemical synthesis, Enantioselective synthesis, CHEMISTRY, lactams, Penicillin- binding proteins, Escherichia coli Infections, Amination, Escherichia coli Infections/drug therapy, Escherichia coli/drug effects, D-ALANINE, BETA-LACTAMASE INHIBITORS, Bacterial Infections, Life sciences, chiral pool, Anti-Bacterial Agents, Molecular Docking Simulation, Chemistry, CONVENIENT SYNTHESIS, ESCHERICHIA-COLI, Sciences du vivant, Computer-Aided Design, Resistant bacteria, Enterococcus faecium/metabolism, ANTIBIOTICS, drug design, Anti-Bacterial Agents/chemical synthesis, biological activity, Biochimie, biophysique & biologie moléculaire, beta-Lactams, beta-Lactams/pharmacology, Catalysis, Anti-Bacterial Agents/pharmacology, Drug Resistance, Bacterial, Escherichia coli, Humans, Penicillin-Binding Proteins, Computer Simulation, BIOLOGICAL EVALUATION, Gram-Positive Bacterial Infections, Gram-Positive Bacterial Infections/drug therapy, Organic Chemistry, Biology and Life Sciences, General Chemistry, ACIDS, Penicillin-Binding Proteins/metabolism, 0104 chemical sciences, Drug Design, Escherichia coli/metabolism, beta-Lactams/chemistry, Enterococcus faecium/drug effects, Penicillin-Binding Proteins/antagonists & inhibitors, Ten-step synthesis, Biochemistry, biophysics & molecular biology
Description: As a complement to the renowned bicyclic β‐lactam antibiotics, monocyclic analogues provide a breath of fresh air in the battle against resistant bacteria. In that framework, the present study discloses the in silico design and unprecedented ten‐step synthesis of eleven nocardicin‐like enantiomerically pure 2‐{3‐[2‐(2‐aminothiazol‐4‐yl)‐2‐(methoxyimino)acetamido]‐2‐oxoazetidin‐1‐yl}acetic acids starting from serine as a readily accessible precursor. The capability of this novel class of monocyclic 3‐amino‐β‐lactams to inhibit penicillin‐binding proteins (PBPs) of various (resistant) bacteria was assessed, revealing the potential of α‐benzylidenecarboxylates as interesting leads in the pursuit of novel PBP inhibitors. No deactivation by representative enzymes belonging to the four β‐lactamase classes was observed, while weak inhibition of class C β‐lactamase P99 was demonstrated.
Document Type: Article
File Description: application/vnd.openxmlformats-officedocument.wordprocessingml.document
Language: English
ISSN: 1521-3765
0947-6539
DOI: 10.1002/chem.201801868
Access URL: http://hdl.handle.net/1854/LU-8598660
https://pubmed.ncbi.nlm.nih.gov/29882610
https://biblio.ugent.be/publication/8598660
https://www.onlinelibrary.wiley.com/doi/abs/10.1002/chem.201801868
https://www.ncbi.nlm.nih.gov/pubmed/29882610
https://onlinelibrary.wiley.com/doi/10.1002/chem.201801868
https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/chem.201801868
http://hdl.handle.net/1854/LU-8598660
https://biblio.ugent.be/publication/8598660/file/8598661
https://biblio.ugent.be/publication/8598660
http://doi.org/10.1002/chem.201801868
Rights: Wiley Online Library User Agreement
Accession Number: edsair.doi.dedup.....12eca35e51846bc894952f1b3ae12323
Database: OpenAIRE
Description
Abstract:As a complement to the renowned bicyclic β‐lactam antibiotics, monocyclic analogues provide a breath of fresh air in the battle against resistant bacteria. In that framework, the present study discloses the in silico design and unprecedented ten‐step synthesis of eleven nocardicin‐like enantiomerically pure 2‐{3‐[2‐(2‐aminothiazol‐4‐yl)‐2‐(methoxyimino)acetamido]‐2‐oxoazetidin‐1‐yl}acetic acids starting from serine as a readily accessible precursor. The capability of this novel class of monocyclic 3‐amino‐β‐lactams to inhibit penicillin‐binding proteins (PBPs) of various (resistant) bacteria was assessed, revealing the potential of α‐benzylidenecarboxylates as interesting leads in the pursuit of novel PBP inhibitors. No deactivation by representative enzymes belonging to the four β‐lactamase classes was observed, while weak inhibition of class C β‐lactamase P99 was demonstrated.
ISSN:15213765
09476539
DOI:10.1002/chem.201801868